Difference between revisions of "Association of the British Pharmaceutical Industry Scotland"
Mira Purska (talk | contribs) (→People) |
Mira Purska (talk | contribs) |
||
| Line 5: | Line 5: | ||
ABPI commissioned a pharmaco-economic research from [[NERA Economic Consulting]] on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. <ref>[http://www.scottish.parliament.uk/business/committees/health/or-06/he06-1602.htm Scottish Parliament Health Committee Official Report 20 June 2006]</ref> | ABPI commissioned a pharmaco-economic research from [[NERA Economic Consulting]] on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. <ref>[http://www.scottish.parliament.uk/business/committees/health/or-06/he06-1602.htm Scottish Parliament Health Committee Official Report 20 June 2006]</ref> | ||
| + | ==Location== | ||
Third Floor East, Crichton House, 4 [[Crichton’s Close]], Canongate, Edinburgh, EH8 8DT | Third Floor East, Crichton House, 4 [[Crichton’s Close]], Canongate, Edinburgh, EH8 8DT | ||
Telephone: +44 (0) 870 890 4333 | Telephone: +44 (0) 870 890 4333 | ||
Revision as of 18:49, 14 January 2008
The ABPI in Scotland is an arm of the Association of the British Pharmaceutical Industry. It works together with the Scottish Parliament, patients, healthcare professionals and managers of the NHS to 'ensure that the people of Scotland have access to the best quality healthcare, including modern medicines'.[1]
The ABPI represents 75 companies in the United Kingdom that research, manufacture and supply 80 per cent of the medicines that the national health service prescribes.
ABPI commissioned a pharmaco-economic research from NERA Economic Consulting on two particular disease areas in Scotland—coronary heart disease and diabetes showing that the level of expenditure on cholesterol lowering medicines—statins is still profitable for NHS in overall terms. [2]
Contents
Location
Third Floor East, Crichton House, 4 Crichton’s Close, Canongate, Edinburgh, EH8 8DT Telephone: +44 (0) 870 890 4333 Fax: +44 (0) 131 523 0491
People
Affiliations
The Royal College of Physicians
